The use of CRISPR/Cas9 as antiviral approach in crop plants can lead to the emergence of new viral variants resistant to CRISPR/Cas9
Researchers from several universities, including Professor Hervé Vanderschuren from Gembloux Agro-Bio Tech, publish important results in the journal Genome Biology.